FGFR2c extracellular domain analogue and new application of coding gene thereof

A technology for encoding genes and extracellular segments, applied in FGFR2c extracellular segment analogs and their encoding genes and applications, can solve problems such as untargeted effective drugs and increased incidence of endometriosis

Pending Publication Date: 2022-08-02
江苏宜仙生物医药有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Individual susceptibility to endometriosis involves multiple factors, including hormonal abnormalities, immune response abnormalities, environmental factors, individual anatomy, and genetic or epigenetic predisposition, etc. Existing studies have also shown that ut

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • FGFR2c extracellular domain analogue and new application of coding gene thereof
  • FGFR2c extracellular domain analogue and new application of coding gene thereof
  • FGFR2c extracellular domain analogue and new application of coding gene thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Clean-grade female adult (9-10 weeks old) non-pregnant SD rats, weighing 190-210g, were randomly divided into sham operation group, model group, and treatment group. Each group finally included 10 rats, and the rats were in the third group. The EM (endometriosis) rat model was established by endometrial autotransplantation during estrus.

[0045] Seven days before the operation, each SD rat was intramuscularly injected with estradiol benzoate (0.1 mg / kg / d) to unify the estrous cycle. Donor SD rats: let them euthanize, take their endometrial tissue, put them in a petri dish filled with normal saline, and remove excess adipose tissue. The uterine segment was cut along the longitudinal axis with ophthalmic scissors, cut into 3mm × 3mm segments, and placed in normal saline for use.

[0046] The recipient SD rats were weighed, and the rats were anesthetized by intraperitoneal injection of 30 mg / ml sodium pentobarbital at 60 mg / kg. Prepare the skin, fix the rat on the steri...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an application of an FGFR2c extracellular domain analogue in preparation of a medicine for preventing and treating endometriosis, and the FGFR2c extracellular domain analogue has a good effect of reducing the size of a mouse endometriosis focus and the fibrosis area, and is superior to that of a gestotrione group. A new means is provided for clinically preparing medicines for treating endometriosis and all diseases related to fibrosis.

Description

technical field [0001] The present invention belongs to the field of biotechnology, and more particularly, the present invention relates to FGFR2c extracellular segment analogs and their encoding genes and applications. Background technique [0002] The extracellular domain of human FGFRs includes three immunoglobulin domains, namely D1, D2, and D3 immunoglobulin-like domains. The D2 and D3 regions are the specific binding regions of FGFs ligands. Twenty-three human FGFs and five FGF receptors (Fgfrs) encoded by different genes have been identified. Different FGF family members play different biological roles, mainly in regulating cell proliferation, cell survival, cell differentiation and cell migration. [0003] In a previous study by the inventor of the present application, Chinese patent application 2020112332925, provided FGFR2c extracellular segment analogs and their encoding genes, which can be applied to inhibit pulmonary fibrosis. [0004] Endometriosis (EMs), th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/17A61P11/00A61P15/00
CPCA61K38/179A61P15/00A61P11/00
Inventor 汪炬
Owner 江苏宜仙生物医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap